P. Jakala et al., Clonidine, but not guanfacine, impairs choice reaction time performance inyoung healthy volunteers, NEUROPSYCH, 21(4), 1999, pp. 495-502
The present study compares the effects of two alpha(2)-adrenoceptor agonist
s, clonidine (0.5, 2, and 5 mu g/kg, p.o.), and guanfacine (7 and 29 mu g/k
g, p.o.), in young healthy volunteers on attentional performance. A placebo
-controlled double-blind cross-over design (one drug dose/group) was employ
ed. Neither of the drugs affected measures of mot or performance or perform
ance at easy levels in an attentional test. However, at the most difficult
level in the attentional test, the highest dose of clonidine (5 mu g/kg), b
at not guanfacine, decreased the number of correct responses and increased
reaction latency. Clonidine 5 and guanfacine 29 mu g/kg equally increased s
ubjective feelings of sedation and reduced systolic and diastolic blood pre
ssures. Thus, the effects of the drugs on attentional performance could be
dissociated from their sedative effects. The results demonstrate that cloni
dine, but not guanfacine, disrupts performance in an attentional task requi
ring effortful processing, while leaving performance intact in tests requir
ing more automatic processing. The lower alpha(2A)-vs. alpha(2C)-adrenocept
or selectivity ratio of clonidine and the affinity for alpha(1)-adrenocepto
rs of clonidine may be responsible for the different action of these drugs
on attention. (C) 1999 American College of Neuropsychopharmacology. Publish
ed by Elsevier Science Inc.